Encouraging Revenue Growth
Revenue for Q2 2025 was $65 million, up from $63.8 million last quarter and $64.6 million in Q2 of 2024, driven by increases in retail revenue from Ohio and Virginia.
Improved Gross Profit and Margin
Gross profit for Q2 2025 was $28.9 million or 44% of revenue, an increase from $25.8 million or 40% in Q1 2025, although down from $32.6 million or 50% in Q2 2024.
Reduction in Net Loss
Net loss for Q2 2025 was $12.3 million, an improvement from $17 million last quarter, although higher than the $1.9 million net loss in the prior year.
Retail Expansion Achievements
Six new locations opened since Q4 2024 as part of the retail expansion strategy, with strategic growth in Ohio and plans to enter the New Jersey market.
Operational Efficiency Gains
Labor optimization initiatives led to a 2% increase in headcount despite a 14% increase in store count, demonstrating successful cost management.
Brand and Product Portfolio Expansion
Launch of 602 new product SKUs in Q2 2025 with strong performance from Seche and The Lab brands.
Progress in Virginia's Delivery Operations
Year-over-year delivery sales growth of approximately 40% in HSA-2 and 108% out of HSA-2, with increased patient engagement.